Advanced Filters
noise

Stroke Clinical Trials

A listing of Stroke medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,429 clinical trials
H Huisheng Chen

Remote Ischemic Conditioning for Acute Moderate Posterior Ischemic Stroke

A substantial body of basic and clinical research has demonstrated the protective effects of remote ischemic conditioning (RIC) in ischemic stroke. While these clinical studies support the safety of RIC, the neuroprotective benefits of RIC in acute ischemic stroke (AIS) patients lack robust evidence due to small sample sizes, heterogeneous …

18 years of age All Phase N/A
Y Yi Yang

Early Tirofiban Administration After Intravenous Thrombolysis in Acute Ischemic Stroke

The purpose of this study is to evaluate the efficacy and safety of early tirofiban administration in patients undergoing IVT

18 years of age All Phase N/A
C Clinical Trials Unit Unidade Local de Saude de Coimbra

Early Doppler-Assisted Mobilization in Adults After Acute Ischemic Stroke

Post-stroke mobilization remains a subject of ongoing debate. While early mobilization-particularly the first out-of-bed mobilization-has been associated with reduced systemic complications and earlier rehabilitation, it also carries potential risks, such as neurological deterioration in the presence of hemodynamic instability. In this study, the primary aim is to investigate whether early …

18 years of age All Phase N/A
H Hongguo Dai

GD-11 for Injection in the Treatment of Acute Ischemic Stroke

Phase III Clinical Trial of GD-11 for Injection in the Treatment of Acute Ischemic Stroke - A Multi-Center, Randomized, Double-Blind, Parallel, Placebo-Controlled Phase III Clinical Study with the primary objective of evaluation of the efficacy and safety of GD-11 for injection in the treatment of acute ischemic stroke patients within …

18 - 81 years of age All Phase 3
s sherihan R. ahmed, MD

Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA

Along with the current clinical trial, the efficacy and safety of a 180 mg loading dose of ticagrelor administered within 24 hours of the first-ever minor stroke or TIA compared to 200mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.

18 - 75 years of age All Phase 3
Y Yongjun Wang

Y-3 for Injection in the Treatment of Acute Ischemic Stroke

This trial aims to evaluate the effectiveness and safety of Y-3 for injection in the treatment of patients with acute ischemic stroke within 48 hours of onset

18 - 81 years of age All Phase 3

Endovascular Therapy Combined With Tirofiban for Intracranial Atherosclerotic Acute Ischemic Stroke

This randomized controlled trial aims to evaluate whether adjunctive tirofiban therapy combined with endovascular treatment (EVT) improves neurological outcomes in patients with acute large vessel occlusion due to large-artery atherosclerosis. Patients will be randomized to receive either tirofiban or matching placebo after EVT. The primary efficacy endpoint is the proportion …

18 years of age All Phase N/A
s sherihan R. ahmed, MD

the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients

The investigators evaluated the impact of AF on different subtypes of post-alteplase hemorrhagic transformation of brain infarction.

18 - 75 years of age All Phase 4
s sherihan R. ahmed, MD

Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA

Along with the current clinical trial, the efficacy and safety of a 300 mg loading dose of clopidogrel administered within 24 hours of the first-ever minor stroke or TIA compared to 200 mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects

18 - 75 years of age All Phase 3
s sherihan R. ahmed, MD

Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIA

Along with the current clinical trial, the efficacy and safety of a 180 mg loading dose of ticagrelor administered within 24 hours of the first-ever minor stroke or TIA compared to 300 mg clopidogrel were assessed through NIHSS, mRS, and possible adverse effects.

18 - 75 years of age All Phase 3

Simplify language using AI